Yurtec Corporation (TYO:1934)
Japan · Delayed Price · Currency is JPY 2,505.00
+29.00 (1.17%)
Aug 1, 2025, 3:30 PM JST
Verve Therapeutics Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 17,261 | 11,700 | 10,430 | 10,175 | 9,107 | Upgrade |
Depreciation & Amortization | - | 4,827 | 4,895 | 5,017 | 4,682 | 4,280 | Upgrade |
Loss (Gain) From Sale of Assets | - | 8 | 139 | 30 | 60 | 32 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | -329 | -1 | Upgrade |
Other Operating Activities | - | -4,576 | -3,894 | -4,198 | -3,853 | -2,255 | Upgrade |
Change in Accounts Receivable | - | 210 | -6,926 | -5,204 | -6,500 | -5,102 | Upgrade |
Change in Inventory | - | 52 | -41 | 242 | 1,737 | -50 | Upgrade |
Change in Accounts Payable | - | -5,057 | 3,234 | 2,600 | 3,799 | -4,303 | Upgrade |
Change in Other Net Operating Assets | - | 2,353 | -1,309 | 775 | -1,841 | 940 | Upgrade |
Operating Cash Flow | - | 15,078 | 7,798 | 9,692 | 7,930 | 2,648 | Upgrade |
Operating Cash Flow Growth | - | 93.36% | -19.54% | 22.22% | 199.47% | -79.94% | Upgrade |
Capital Expenditures | - | -4,001 | -6,093 | -3,863 | -4,051 | -2,900 | Upgrade |
Sale of Property, Plant & Equipment | - | 165 | 61 | 205 | 60 | 16 | Upgrade |
Cash Acquisitions | - | -20 | -360 | -690 | -4,462 | -285 | Upgrade |
Sale (Purchase) of Intangibles | - | -1,373 | -632 | -823 | -896 | -619 | Upgrade |
Investment in Securities | - | -1,388 | 51 | 23 | 1,003 | 952 | Upgrade |
Other Investing Activities | - | 777 | 11,249 | -158 | -1,610 | -1,803 | Upgrade |
Investing Cash Flow | - | -5,803 | 4,318 | -5,303 | -9,808 | -4,621 | Upgrade |
Short-Term Debt Issued | - | 1,047 | - | - | - | - | Upgrade |
Long-Term Debt Issued | - | 2,700 | 2,400 | 2,400 | 3,300 | 1,600 | Upgrade |
Total Debt Issued | - | 3,747 | 2,400 | 2,400 | 3,300 | 1,600 | Upgrade |
Short-Term Debt Repaid | - | - | -1,017 | -2,695 | -284 | - | Upgrade |
Long-Term Debt Repaid | - | -2,411 | -2,723 | -2,846 | -3,019 | -3,209 | Upgrade |
Total Debt Repaid | - | -2,411 | -3,740 | -5,541 | -3,303 | -3,209 | Upgrade |
Net Debt Issued (Repaid) | - | 1,336 | -1,340 | -3,141 | -3 | -1,609 | Upgrade |
Repurchase of Common Stock | - | -4,511 | - | - | - | - | Upgrade |
Dividends Paid | - | -3,643 | -2,003 | -2,285 | -1,429 | -1,429 | Upgrade |
Other Financing Activities | - | -18 | -25 | -24 | -23 | -21 | Upgrade |
Financing Cash Flow | - | -6,836 | -3,368 | -5,450 | -1,455 | -3,059 | Upgrade |
Foreign Exchange Rate Adjustments | - | -155 | 323 | 356 | 87 | 15 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -2 | - | - | 1 | - | Upgrade |
Net Cash Flow | - | 2,282 | 9,071 | -705 | -3,245 | -5,017 | Upgrade |
Free Cash Flow | - | 11,077 | 1,705 | 5,829 | 3,879 | -252 | Upgrade |
Free Cash Flow Growth | - | 549.68% | -70.75% | 50.27% | - | - | Upgrade |
Free Cash Flow Margin | - | 4.31% | 0.70% | 2.56% | 1.72% | -0.13% | Upgrade |
Free Cash Flow Per Share | - | 157.08 | 23.80 | 81.45 | 54.24 | -3.52 | Upgrade |
Cash Interest Paid | - | 14 | 24 | 102 | 245 | 9 | Upgrade |
Cash Income Tax Paid | - | 4,573 | 3,896 | 4,202 | 3,852 | 2,255 | Upgrade |
Levered Free Cash Flow | - | 10,133 | -634.25 | 4,629 | -2,384 | 954.5 | Upgrade |
Unlevered Free Cash Flow | - | 10,142 | -620.5 | 4,693 | -2,231 | 960.13 | Upgrade |
Change in Net Working Capital | 2,264 | -573 | 5,368 | 1,540 | 7,900 | 5,104 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.